 Nanduri R. Prabhakar
Concepts (699)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Body | 125 | 2021 | 223 | 30.060 |
Why?
| | Oxygen | 65 | 2020 | 731 | 11.160 |
Why?
| | Reactive Oxygen Species | 46 | 2022 | 461 | 7.710 |
Why?
| | Hydrogen Sulfide | 15 | 2021 | 45 | 6.590 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 27 | 2022 | 155 | 6.440 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 14 | 2020 | 161 | 5.580 |
Why?
| | Chemoreceptor Cells | 42 | 2019 | 66 | 5.390 |
Why?
| | Sleep Apnea Syndromes | 17 | 2018 | 123 | 4.790 |
Why?
| | Adrenal Medulla | 16 | 2019 | 47 | 4.470 |
Why?
| | Cell Hypoxia | 31 | 2022 | 163 | 4.230 |
Why?
| | Hypoxia-Inducible Factor 1 | 13 | 2020 | 41 | 4.210 |
Why?
| | Chromaffin Cells | 12 | 2021 | 37 | 4.170 |
Why?
| | Catecholamines | 15 | 2021 | 101 | 4.070 |
Why?
| | Animals | 221 | 2022 | 27167 | 3.940 |
Why?
| | Carbon Monoxide | 15 | 2021 | 92 | 3.890 |
Why?
| | Rats | 81 | 2022 | 4351 | 3.820 |
Why?
| | Cystathionine gamma-Lyase | 10 | 2021 | 35 | 3.630 |
Why?
| | Oxidative Stress | 16 | 2015 | 412 | 3.530 |
Why?
| | Hypertension | 13 | 2021 | 1215 | 3.490 |
Why?
| | Respiration | 37 | 2021 | 245 | 3.480 |
Why?
| | Rats, Sprague-Dawley | 49 | 2019 | 1365 | 3.210 |
Why?
| | Sympathetic Nervous System | 15 | 2021 | 113 | 3.120 |
Why?
| | Reflex | 13 | 2016 | 74 | 3.110 |
Why?
| | Heme Oxygenase (Decyclizing) | 13 | 2021 | 39 | 3.030 |
Why?
| | Receptors, Odorant | 3 | 2021 | 32 | 2.540 |
Why?
| | Signal Transduction | 24 | 2021 | 3315 | 2.370 |
Why?
| | Calcium | 25 | 2018 | 1237 | 2.260 |
Why?
| | Epigenesis, Genetic | 8 | 2020 | 441 | 2.030 |
Why?
| | PC12 Cells | 26 | 2021 | 121 | 1.950 |
Why?
| | Sleep Apnea, Obstructive | 5 | 2021 | 265 | 1.910 |
Why?
| | Substance P | 17 | 2011 | 60 | 1.830 |
Why?
| | Animals, Newborn | 15 | 2019 | 564 | 1.800 |
Why?
| | Gases | 4 | 2018 | 28 | 1.800 |
Why?
| | Blood Pressure | 34 | 2018 | 1207 | 1.780 |
Why?
| | Respiratory Mechanics | 7 | 2013 | 106 | 1.760 |
Why?
| | Apnea | 8 | 2019 | 30 | 1.690 |
Why?
| | Mice | 43 | 2021 | 11210 | 1.650 |
Why?
| | Neuronal Plasticity | 10 | 2013 | 238 | 1.640 |
Why?
| | Calcium Channels, T-Type | 3 | 2015 | 27 | 1.600 |
Why?
| | Nitric Oxide Synthase | 13 | 2012 | 127 | 1.540 |
Why?
| | Nitric Oxide | 14 | 2012 | 272 | 1.500 |
Why?
| | Mice, Knockout | 22 | 2021 | 1962 | 1.490 |
Why?
| | Phrenic Nerve | 22 | 2018 | 45 | 1.490 |
Why?
| | Gene Expression Regulation | 16 | 2017 | 1960 | 1.430 |
Why?
| | DNA Methylation | 6 | 2018 | 581 | 1.390 |
Why?
| | Male | 100 | 2021 | 42139 | 1.320 |
Why?
| | Oxygen Consumption | 16 | 2017 | 250 | 1.320 |
Why?
| | Physiology | 3 | 2020 | 15 | 1.320 |
Why?
| | Calcium Channels | 10 | 2014 | 202 | 1.290 |
Why?
| | Disease Models, Animal | 13 | 2021 | 2318 | 1.280 |
Why?
| | Sensory Receptor Cells | 2 | 2018 | 36 | 1.270 |
Why?
| | Ether-A-Go-Go Potassium Channels | 7 | 2019 | 27 | 1.260 |
Why?
| | Medicine | 2 | 2020 | 74 | 1.250 |
Why?
| | Respiration Disorders | 3 | 2016 | 43 | 1.190 |
Why?
| | Protein Processing, Post-Translational | 8 | 2015 | 377 | 1.150 |
Why?
| | Norepinephrine | 9 | 2021 | 182 | 1.140 |
Why?
| | Homeostasis | 9 | 2017 | 400 | 1.130 |
Why?
| | Mitochondria | 10 | 2013 | 536 | 1.130 |
Why?
| | Xanthine Oxidase | 2 | 2015 | 26 | 1.110 |
Why?
| | Lung | 5 | 2015 | 1079 | 1.030 |
Why?
| | Humans | 85 | 2020 | 84202 | 1.020 |
Why?
| | Carbon Dioxide | 18 | 2012 | 199 | 1.000 |
Why?
| | Chronic Disease | 13 | 2021 | 978 | 0.990 |
Why?
| | Membrane Glycoproteins | 4 | 2015 | 437 | 0.990 |
Why?
| | Carotid Sinus | 11 | 2015 | 26 | 0.980 |
Why?
| | Oxidation-Reduction | 6 | 2016 | 382 | 0.970 |
Why?
| | Enzyme Activation | 14 | 2015 | 739 | 0.930 |
Why?
| | Cats | 41 | 2008 | 305 | 0.930 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 12 | 0.910 |
Why?
| | Tyrosine 3-Monooxygenase | 9 | 2012 | 48 | 0.910 |
Why?
| | Neurons, Afferent | 7 | 2008 | 83 | 0.910 |
Why?
| | Genes, fos | 8 | 2004 | 24 | 0.900 |
Why?
| | Pheochromocytoma | 1 | 2021 | 67 | 0.880 |
Why?
| | Erythropoietin | 1 | 2021 | 93 | 0.850 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2021 | 101 | 0.850 |
Why?
| | Respiratory Physiological Phenomena | 5 | 2006 | 47 | 0.840 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 15 | 0.830 |
Why?
| | Olfactory Receptor Neurons | 1 | 2020 | 17 | 0.830 |
Why?
| | Transcriptional Activation | 7 | 2021 | 287 | 0.830 |
Why?
| | Nobel Prize | 1 | 2020 | 11 | 0.830 |
Why?
| | Hypoxia, Brain | 3 | 2014 | 39 | 0.800 |
Why?
| | Serotonin | 5 | 2011 | 241 | 0.800 |
Why?
| | Electron Transport Complex I | 4 | 2018 | 23 | 0.800 |
Why?
| | Neurotransmitter Agents | 7 | 2014 | 112 | 0.790 |
Why?
| | Calcium Channels, L-Type | 6 | 2002 | 45 | 0.770 |
Why?
| | Potassium Channels | 8 | 2005 | 348 | 0.760 |
Why?
| | Protein Kinase C | 8 | 2015 | 301 | 0.760 |
Why?
| | Ion Channels | 3 | 2014 | 262 | 0.750 |
Why?
| | Calcium Channel Blockers | 10 | 2012 | 234 | 0.750 |
Why?
| | Proto-Oncogene Proteins c-fos | 4 | 2005 | 69 | 0.750 |
Why?
| | Sulfites | 1 | 2018 | 24 | 0.740 |
Why?
| | Enzyme Inhibitors | 16 | 2012 | 675 | 0.740 |
Why?
| | Transcription, Genetic | 5 | 2015 | 1173 | 0.720 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 3200 | 0.710 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2020 | 385 | 0.710 |
Why?
| | Transcription Factors | 6 | 2008 | 1525 | 0.680 |
Why?
| | Cells, Cultured | 16 | 2018 | 2974 | 0.680 |
Why?
| | Second Messenger Systems | 3 | 2012 | 41 | 0.670 |
Why?
| | Endothelin-1 | 3 | 2013 | 44 | 0.670 |
Why?
| | Sensation | 1 | 2017 | 46 | 0.640 |
Why?
| | Calpain | 3 | 2015 | 111 | 0.640 |
Why?
| | Respiratory System | 6 | 2016 | 115 | 0.630 |
Why?
| | Arteries | 3 | 2015 | 193 | 0.630 |
Why?
| | Action Potentials | 14 | 2018 | 635 | 0.620 |
Why?
| | Vagus Nerve | 5 | 2008 | 47 | 0.610 |
Why?
| | Cation Transport Proteins | 3 | 2001 | 60 | 0.610 |
Why?
| | Phosphorylation | 9 | 2015 | 1161 | 0.610 |
Why?
| | Adaptation, Physiological | 5 | 2012 | 325 | 0.610 |
Why?
| | Rabbits | 19 | 2007 | 729 | 0.610 |
Why?
| | Genes, Immediate-Early | 4 | 2004 | 18 | 0.600 |
Why?
| | Cyclic GMP-Dependent Protein Kinases | 1 | 2015 | 14 | 0.600 |
Why?
| | Superoxide Dismutase | 6 | 2016 | 186 | 0.580 |
Why?
| | Transcription Factor AP-1 | 5 | 2005 | 66 | 0.580 |
Why?
| | Potassium Channels, Voltage-Gated | 3 | 2001 | 117 | 0.580 |
Why?
| | Respiratory Muscles | 5 | 2008 | 16 | 0.570 |
Why?
| | Dopamine | 11 | 2019 | 294 | 0.570 |
Why?
| | Angiotensin II | 2 | 2012 | 94 | 0.560 |
Why?
| | Hypercapnia | 9 | 2007 | 50 | 0.550 |
Why?
| | Neprilysin | 4 | 2000 | 41 | 0.550 |
Why?
| | Long-Term Potentiation | 4 | 2011 | 65 | 0.540 |
Why?
| | Protein Kinases | 5 | 2012 | 225 | 0.530 |
Why?
| | Pulmonary Edema | 1 | 2014 | 55 | 0.520 |
Why?
| | Cardiovascular System | 4 | 2013 | 74 | 0.520 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 101 | 0.520 |
Why?
| | Metalloendopeptidases | 1 | 2013 | 49 | 0.520 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2013 | 65 | 0.510 |
Why?
| | Peripheral Nervous System | 3 | 2011 | 20 | 0.500 |
Why?
| | Pressoreceptors | 2 | 2011 | 21 | 0.490 |
Why?
| | Nerve Net | 2 | 2015 | 378 | 0.490 |
Why?
| | Energy Metabolism | 2 | 2017 | 267 | 0.490 |
Why?
| | Fetal Hypoxia | 1 | 2012 | 14 | 0.490 |
Why?
| | Endothelins | 2 | 2010 | 34 | 0.490 |
Why?
| | Acetylcholine | 8 | 2014 | 186 | 0.480 |
Why?
| | Pulmonary Ventilation | 4 | 2012 | 36 | 0.470 |
Why?
| | Up-Regulation | 8 | 2015 | 715 | 0.470 |
Why?
| | Endothelial Cells | 2 | 2017 | 404 | 0.470 |
Why?
| | Academies and Institutes | 1 | 2011 | 27 | 0.460 |
Why?
| | Central Nervous System | 3 | 2011 | 148 | 0.460 |
Why?
| | Time Factors | 16 | 2014 | 5516 | 0.460 |
Why?
| | Molecular Biology | 1 | 2012 | 87 | 0.450 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 4 | 2004 | 93 | 0.450 |
Why?
| | Medulla Oblongata | 16 | 2004 | 82 | 0.450 |
Why?
| | Acclimatization | 3 | 2009 | 71 | 0.450 |
Why?
| | RNA, Messenger | 10 | 2013 | 2008 | 0.440 |
Why?
| | Calcium Signaling | 2 | 2009 | 137 | 0.440 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2010 | 10 | 0.440 |
Why?
| | Antioxidants | 7 | 2013 | 230 | 0.440 |
Why?
| | DNA-Binding Proteins | 5 | 2014 | 1213 | 0.440 |
Why?
| | Heart | 3 | 2012 | 536 | 0.430 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2014 | 225 | 0.430 |
Why?
| | HSP90 Heat-Shock Proteins | 2 | 2019 | 47 | 0.430 |
Why?
| | Immunohistochemistry | 8 | 2018 | 1830 | 0.430 |
Why?
| | Tachykinins | 3 | 2003 | 12 | 0.430 |
Why?
| | Universities | 1 | 2011 | 136 | 0.430 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 1 | 2010 | 25 | 0.420 |
Why?
| | Exocytosis | 1 | 2010 | 109 | 0.410 |
Why?
| | Brain Stem | 8 | 2018 | 164 | 0.400 |
Why?
| | Patch-Clamp Techniques | 9 | 2011 | 454 | 0.400 |
Why?
| | Respiratory Center | 2 | 2011 | 53 | 0.400 |
Why?
| | Laboratory Animal Science | 1 | 2009 | 6 | 0.400 |
Why?
| | Membrane Potentials | 9 | 2010 | 482 | 0.400 |
Why?
| | Metalloporphyrins | 6 | 2013 | 27 | 0.390 |
Why?
| | Receptors, Serotonin, 5-HT2 | 2 | 2009 | 14 | 0.390 |
Why?
| | Receptors, Nicotinic | 1 | 2010 | 131 | 0.390 |
Why?
| | Protein Transport | 4 | 2019 | 421 | 0.390 |
Why?
| | Superoxides | 4 | 2012 | 83 | 0.390 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2008 | 10 | 0.380 |
Why?
| | Pulmonary Gas Exchange | 2 | 2006 | 35 | 0.380 |
Why?
| | Telemetry | 1 | 2009 | 37 | 0.380 |
Why?
| | Gene Expression | 7 | 2016 | 1341 | 0.380 |
Why?
| | Electrophysiology | 7 | 2006 | 439 | 0.370 |
Why?
| | Partial Pressure | 9 | 2012 | 53 | 0.370 |
Why?
| | GTP-Binding Proteins | 3 | 2000 | 163 | 0.370 |
Why?
| | Blood Pressure Determination | 1 | 2009 | 97 | 0.370 |
Why?
| | Cyclic GMP | 5 | 1999 | 61 | 0.360 |
Why?
| | Hydrogen Peroxide | 5 | 2020 | 166 | 0.350 |
Why?
| | Nerve Tissue Proteins | 3 | 1996 | 530 | 0.350 |
Why?
| | Cardiovascular Diseases | 2 | 2012 | 819 | 0.350 |
Why?
| | Potassium Chloride | 4 | 2012 | 90 | 0.350 |
Why?
| | History, 21st Century | 3 | 2020 | 182 | 0.350 |
Why?
| | Female | 44 | 2021 | 45031 | 0.350 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2007 | 17 | 0.330 |
Why?
| | Neurons | 8 | 2011 | 1618 | 0.330 |
Why?
| | Baroreflex | 2 | 2020 | 19 | 0.320 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2006 | 37 | 0.320 |
Why?
| | Models, Biological | 8 | 2020 | 1799 | 0.320 |
Why?
| | HEK293 Cells | 4 | 2019 | 646 | 0.320 |
Why?
| | Mice, Transgenic | 3 | 2021 | 1560 | 0.320 |
Why?
| | Biphenyl Compounds | 3 | 2000 | 69 | 0.310 |
Why?
| | Regional Blood Flow | 3 | 2017 | 208 | 0.310 |
Why?
| | Afferent Pathways | 5 | 2005 | 79 | 0.310 |
Why?
| | Alkynes | 2 | 2018 | 20 | 0.300 |
Why?
| | Models, Cardiovascular | 2 | 2017 | 104 | 0.300 |
Why?
| | Adenosine Triphosphate | 3 | 2014 | 311 | 0.300 |
Why?
| | Brain | 8 | 2018 | 2165 | 0.300 |
Why?
| | Hemeproteins | 2 | 2005 | 17 | 0.290 |
Why?
| | Glycine | 2 | 2018 | 99 | 0.290 |
Why?
| | Malondialdehyde | 3 | 2016 | 30 | 0.290 |
Why?
| | Altitude | 2 | 2002 | 42 | 0.290 |
Why?
| | Free Radical Scavengers | 1 | 2005 | 63 | 0.290 |
Why?
| | Insulin | 4 | 2020 | 1172 | 0.280 |
Why?
| | Trans-Activators | 3 | 2004 | 446 | 0.280 |
Why?
| | Electrochemistry | 3 | 2010 | 67 | 0.280 |
Why?
| | Benzazepines | 3 | 2021 | 93 | 0.280 |
Why?
| | Altitude Sickness | 1 | 2004 | 10 | 0.270 |
Why?
| | Down-Regulation | 4 | 2010 | 526 | 0.270 |
Why?
| | Bicarbonates | 2 | 2001 | 70 | 0.270 |
Why?
| | Transfection | 3 | 2021 | 946 | 0.270 |
Why?
| | Hemoglobins, Abnormal | 1 | 2003 | 5 | 0.270 |
Why?
| | Hemoglobinopathies | 1 | 2003 | 10 | 0.270 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2002 | 555 | 0.270 |
Why?
| | Protein Isoforms | 2 | 2015 | 270 | 0.260 |
Why?
| | Diaphragm | 4 | 2001 | 57 | 0.260 |
Why?
| | Neuroblastoma | 3 | 2016 | 369 | 0.260 |
Why?
| | Sulfides | 2 | 2014 | 66 | 0.260 |
Why?
| | Cytosol | 3 | 2000 | 196 | 0.250 |
Why?
| | Proteins | 1 | 2008 | 783 | 0.250 |
Why?
| | Cadmium Chloride | 3 | 2012 | 12 | 0.250 |
Why?
| | Nuclear Proteins | 3 | 2004 | 698 | 0.250 |
Why?
| | Motor Neurons | 5 | 2008 | 162 | 0.240 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 2009 | 324 | 0.240 |
Why?
| | Insulin Resistance | 3 | 2020 | 391 | 0.240 |
Why?
| | Periodicity | 1 | 2003 | 125 | 0.240 |
Why?
| | Adrenergic alpha-Agonists | 2 | 1999 | 38 | 0.240 |
Why?
| | Aconitate Hydratase | 2 | 2016 | 11 | 0.240 |
Why?
| | Analysis of Variance | 5 | 2011 | 965 | 0.240 |
Why?
| | Histone Deacetylases | 1 | 2022 | 63 | 0.230 |
Why?
| | Receptor, Endothelin A | 2 | 2013 | 24 | 0.230 |
Why?
| | Dose-Response Relationship, Drug | 9 | 2011 | 2104 | 0.220 |
Why?
| | Splanchnic Nerves | 2 | 2014 | 7 | 0.220 |
Why?
| | Heterozygote | 3 | 2020 | 375 | 0.220 |
Why?
| | Carotid Arteries | 2 | 2019 | 137 | 0.220 |
Why?
| | Adenosine | 4 | 1994 | 223 | 0.210 |
Why?
| | Nitric Oxide Synthase Type I | 4 | 2002 | 22 | 0.210 |
Why?
| | Gene Silencing | 1 | 2021 | 183 | 0.210 |
Why?
| | Glycopeptides | 3 | 2000 | 19 | 0.210 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2014 | 184 | 0.210 |
Why?
| | Potassium | 6 | 2007 | 308 | 0.210 |
Why?
| | Plethysmography, Whole Body | 3 | 2011 | 9 | 0.200 |
Why?
| | Electric Stimulation | 8 | 2011 | 377 | 0.200 |
Why?
| | Immunoblotting | 2 | 2013 | 279 | 0.190 |
Why?
| | NADH Dehydrogenase | 1 | 2018 | 23 | 0.190 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 62 | 0.190 |
Why?
| | Muscles | 3 | 2014 | 194 | 0.190 |
Why?
| | Infant, Premature, Diseases | 1 | 2019 | 86 | 0.190 |
Why?
| | Receptors, Drug | 1 | 1998 | 58 | 0.180 |
Why?
| | omega-Conotoxins | 1 | 1997 | 3 | 0.180 |
Why?
| | Pyrimidines | 1 | 2021 | 402 | 0.180 |
Why?
| | Hypoglossal Nerve | 4 | 2013 | 19 | 0.180 |
Why?
| | Blotting, Western | 3 | 2011 | 834 | 0.180 |
Why?
| | Aortic Bodies | 2 | 2003 | 2 | 0.180 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 4 | 2011 | 59 | 0.170 |
Why?
| | Digoxin | 2 | 2020 | 24 | 0.170 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 3 | 2003 | 98 | 0.170 |
Why?
| | Indazoles | 2 | 2011 | 71 | 0.170 |
Why?
| | Tidal Volume | 7 | 2005 | 52 | 0.170 |
Why?
| | Rats, Inbred SHR | 1 | 2017 | 29 | 0.170 |
Why?
| | Rats, Inbred WKY | 1 | 2017 | 31 | 0.170 |
Why?
| | Nicotine | 3 | 2010 | 170 | 0.170 |
Why?
| | Epinephrine | 2 | 2006 | 87 | 0.170 |
Why?
| | Genes, jun | 2 | 1996 | 18 | 0.170 |
Why?
| | Capsaicin | 3 | 1993 | 47 | 0.170 |
Why?
| | Peroxiredoxins | 1 | 2016 | 14 | 0.160 |
Why?
| | Glutathione Peroxidase | 1 | 2016 | 25 | 0.160 |
Why?
| | Catalase | 1 | 2016 | 57 | 0.160 |
Why?
| | Systems Biology | 1 | 2017 | 46 | 0.160 |
Why?
| | Serotonin Antagonists | 2 | 2006 | 40 | 0.160 |
Why?
| | Nodose Ganglion | 1 | 1996 | 5 | 0.160 |
Why?
| | Protein Biosynthesis | 2 | 2008 | 379 | 0.160 |
Why?
| | Ketanserin | 2 | 2006 | 10 | 0.160 |
Why?
| | Cell Line | 3 | 2009 | 2620 | 0.160 |
Why?
| | Benzeneacetamides | 1 | 2015 | 13 | 0.160 |
Why?
| | Microscopy, Fluorescence | 1 | 2018 | 443 | 0.160 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2016 | 1213 | 0.160 |
Why?
| | Enhancer Elements, Genetic | 1 | 1998 | 268 | 0.150 |
Why?
| | Cell Membrane | 3 | 2005 | 691 | 0.150 |
Why?
| | Ion Channel Gating | 1 | 1999 | 336 | 0.150 |
Why?
| | Mixed Function Oxygenases | 3 | 2014 | 66 | 0.150 |
Why?
| | Nisoldipine | 3 | 2000 | 5 | 0.150 |
Why?
| | History, 20th Century | 2 | 2010 | 319 | 0.150 |
Why?
| | Solitary Nucleus | 2 | 2014 | 21 | 0.150 |
Why?
| | Infant, Newborn | 3 | 2012 | 2457 | 0.150 |
Why?
| | Heme | 1 | 2015 | 63 | 0.150 |
Why?
| | Adrenal Cortex | 2 | 2012 | 23 | 0.150 |
Why?
| | Deferoxamine | 2 | 2011 | 20 | 0.150 |
Why?
| | Siderophores | 2 | 2011 | 21 | 0.150 |
Why?
| | Amino Acid Motifs | 1 | 2015 | 121 | 0.140 |
Why?
| | Cell Survival | 3 | 2004 | 1016 | 0.140 |
Why?
| | Sulfonamides | 3 | 2004 | 330 | 0.140 |
Why?
| | Adaptation, Psychological | 1 | 2015 | 155 | 0.140 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 452 | 0.140 |
Why?
| | Cysteine | 1 | 2015 | 135 | 0.140 |
Why?
| | Cystathionine beta-Synthase | 1 | 2014 | 3 | 0.140 |
Why?
| | Aging | 2 | 2008 | 668 | 0.140 |
Why?
| | Acute Disease | 2 | 2006 | 868 | 0.140 |
Why?
| | Mice, Mutant Strains | 3 | 2011 | 252 | 0.140 |
Why?
| | Biomedical Research | 2 | 2009 | 357 | 0.140 |
Why?
| | Hyperinsulinism | 1 | 2014 | 50 | 0.140 |
Why?
| | Neuropeptide Y | 2 | 2011 | 32 | 0.130 |
Why?
| | Cerebellum | 1 | 1996 | 235 | 0.130 |
Why?
| | Insulin-Secreting Cells | 2 | 2020 | 405 | 0.130 |
Why?
| | Fibroblasts | 3 | 2011 | 732 | 0.130 |
Why?
| | Intercellular Junctions | 1 | 2014 | 73 | 0.130 |
Why?
| | Electric Impedance | 1 | 2014 | 102 | 0.130 |
Why?
| | Reproducibility of Results | 3 | 2016 | 2685 | 0.130 |
Why?
| | Interleukins | 1 | 2014 | 127 | 0.130 |
Why?
| | Cold Temperature | 5 | 1989 | 162 | 0.130 |
Why?
| | Pyridines | 1 | 2015 | 310 | 0.130 |
Why?
| | Reference Values | 3 | 2002 | 704 | 0.130 |
Why?
| | Software | 1 | 2018 | 654 | 0.130 |
Why?
| | Neurokinin A | 2 | 1990 | 12 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2020 | 1300 | 0.120 |
Why?
| | Protoporphyrins | 3 | 1998 | 20 | 0.120 |
Why?
| | Gene Expression Profiling | 3 | 2017 | 1383 | 0.120 |
Why?
| | Nifedipine | 1 | 2012 | 33 | 0.120 |
Why?
| | Ischemic Preconditioning, Myocardial | 1 | 2012 | 14 | 0.120 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2012 | 7 | 0.120 |
Why?
| | Arousal | 1 | 2013 | 169 | 0.120 |
Why?
| | Polysomnography | 1 | 2013 | 188 | 0.120 |
Why?
| | Cytoskeleton | 1 | 2014 | 193 | 0.120 |
Why?
| | Erythropoiesis | 1 | 2012 | 50 | 0.120 |
Why?
| | Multienzyme Complexes | 2 | 2011 | 66 | 0.120 |
Why?
| | Intercostal Muscles | 4 | 1988 | 5 | 0.120 |
Why?
| | Hypnotics and Sedatives | 1 | 1993 | 133 | 0.120 |
Why?
| | Blood Vessels | 1 | 2012 | 98 | 0.120 |
Why?
| | KATP Channels | 1 | 2012 | 19 | 0.120 |
Why?
| | Body Weight | 1 | 2014 | 504 | 0.120 |
Why?
| | Furans | 1 | 2011 | 18 | 0.120 |
Why?
| | Faculty | 1 | 2011 | 16 | 0.120 |
Why?
| | Cadmium | 2 | 2009 | 30 | 0.120 |
Why?
| | Potassium Channel Blockers | 3 | 2003 | 65 | 0.120 |
Why?
| | Aldosterone | 1 | 2012 | 63 | 0.120 |
Why?
| | Species Specificity | 1 | 2014 | 696 | 0.120 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2011 | 21 | 0.110 |
Why?
| | Synaptic Transmission | 2 | 2012 | 287 | 0.110 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 1991 | 17 | 0.110 |
Why?
| | Genes, Reporter | 2 | 2004 | 269 | 0.110 |
Why?
| | CpG Islands | 1 | 2012 | 144 | 0.110 |
Why?
| | Particulate Matter | 1 | 2011 | 50 | 0.110 |
Why?
| | Vagotomy | 5 | 2004 | 12 | 0.110 |
Why?
| | Receptors, Adrenergic, alpha-2 | 3 | 1998 | 15 | 0.110 |
Why?
| | Eledoisin | 1 | 1990 | 1 | 0.110 |
Why?
| | Physalaemin | 1 | 1990 | 1 | 0.110 |
Why?
| | Time | 1 | 2011 | 84 | 0.110 |
Why?
| | Air Pollutants | 1 | 2011 | 50 | 0.110 |
Why?
| | Oxidants | 1 | 2011 | 89 | 0.110 |
Why?
| | Isoenzymes | 3 | 2012 | 277 | 0.110 |
Why?
| | Indoles | 3 | 2000 | 335 | 0.110 |
Why?
| | Receptors, Neurotransmitter | 1 | 1990 | 33 | 0.110 |
Why?
| | Blood Gas Analysis | 3 | 2005 | 47 | 0.110 |
Why?
| | Glutamate Decarboxylase | 1 | 2010 | 33 | 0.110 |
Why?
| | Genomics | 1 | 2016 | 657 | 0.110 |
Why?
| | Sodium Channels | 1 | 2011 | 129 | 0.110 |
Why?
| | Guanabenz | 3 | 1998 | 4 | 0.110 |
Why?
| | Receptors, Dopamine D1 | 1 | 2010 | 37 | 0.110 |
Why?
| | Glutathione | 1 | 2010 | 108 | 0.110 |
Why?
| | Tumor Cells, Cultured | 3 | 1998 | 1088 | 0.100 |
Why?
| | Recurrence | 2 | 2004 | 1200 | 0.100 |
Why?
| | Phenethylamines | 2 | 2000 | 8 | 0.100 |
Why?
| | Trachea | 2 | 2008 | 309 | 0.100 |
Why?
| | Genetics, Medical | 1 | 2010 | 52 | 0.100 |
Why?
| | Enkephalin, Methionine | 2 | 2000 | 4 | 0.100 |
Why?
| | Kinetics | 3 | 2008 | 1624 | 0.100 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2000 | 24 | 0.100 |
Why?
| | Infant, Premature | 1 | 2012 | 287 | 0.100 |
Why?
| | Acetylcysteine | 2 | 2011 | 75 | 0.100 |
Why?
| | Lung Volume Measurements | 2 | 2008 | 21 | 0.100 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2000 | 83 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 679 | 0.100 |
Why?
| | Sodium Cyanide | 2 | 2004 | 6 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 1 | 2011 | 212 | 0.100 |
Why?
| | Neural Conduction | 2 | 2006 | 66 | 0.100 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2000 | 89 | 0.100 |
Why?
| | Hydrolysis | 2 | 2000 | 154 | 0.100 |
Why?
| | Protein Phosphatase 2 | 1 | 2009 | 17 | 0.100 |
Why?
| | Mitochondria, Heart | 1 | 1989 | 47 | 0.100 |
Why?
| | Renin-Angiotensin System | 1 | 2010 | 133 | 0.100 |
Why?
| | Dinitrophenols | 1 | 1989 | 6 | 0.100 |
Why?
| | Cell Line, Tumor | 4 | 2019 | 2437 | 0.100 |
Why?
| | Maleimides | 2 | 2000 | 31 | 0.100 |
Why?
| | Egtazic Acid | 2 | 2000 | 38 | 0.100 |
Why?
| | Staurosporine | 2 | 2000 | 44 | 0.100 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 10 | 0.100 |
Why?
| | Hydroxylation | 1 | 2008 | 16 | 0.100 |
Why?
| | Extracellular Fluid | 1 | 2009 | 23 | 0.100 |
Why?
| | Phospholipase C gamma | 1 | 2008 | 14 | 0.100 |
Why?
| | Heart Rate | 3 | 2009 | 564 | 0.100 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1078 | 0.090 |
Why?
| | Thoracic Wall | 1 | 2008 | 21 | 0.090 |
Why?
| | Respiratory Tract Diseases | 1 | 2009 | 44 | 0.090 |
Why?
| | Hyperoxia | 1 | 2008 | 39 | 0.090 |
Why?
| | Spirometry | 1 | 2008 | 68 | 0.090 |
Why?
| | Elasticity | 1 | 2008 | 88 | 0.090 |
Why?
| | Anaerobiosis | 1 | 2008 | 22 | 0.090 |
Why?
| | Autonomic Nervous System | 1 | 2009 | 56 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 927 | 0.090 |
Why?
| | Ion Transport | 2 | 2000 | 86 | 0.090 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 121 | 0.090 |
Why?
| | Oligopeptides | 1 | 2009 | 186 | 0.090 |
Why?
| | Thermodynamics | 1 | 2008 | 309 | 0.090 |
Why?
| | Anesthetics, Intravenous | 1 | 2007 | 50 | 0.090 |
Why?
| | Hippocampus | 1 | 2011 | 463 | 0.090 |
Why?
| | Receptors, Neurokinin-1 | 2 | 2000 | 13 | 0.080 |
Why?
| | Sirolimus | 1 | 2008 | 173 | 0.080 |
Why?
| | Methysergide | 1 | 2006 | 6 | 0.080 |
Why?
| | Secretory Vesicles | 1 | 2007 | 43 | 0.080 |
Why?
| | Propofol | 1 | 2007 | 96 | 0.080 |
Why?
| | Neural Pathways | 1 | 2009 | 300 | 0.080 |
Why?
| | Nerve Fibers | 2 | 1986 | 44 | 0.080 |
Why?
| | Acetophenones | 1 | 2006 | 28 | 0.080 |
Why?
| | Nerve Endings | 1 | 1986 | 16 | 0.080 |
Why?
| | Chicago | 1 | 2011 | 1455 | 0.080 |
Why?
| | Phosphoprotein Phosphatases | 2 | 2012 | 58 | 0.080 |
Why?
| | Receptors, Serotonin | 1 | 2006 | 60 | 0.080 |
Why?
| | Nociceptors | 1 | 1986 | 27 | 0.080 |
Why?
| | Autocrine Communication | 1 | 2005 | 18 | 0.080 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2005 | 28 | 0.080 |
Why?
| | Enzyme Induction | 2 | 1996 | 93 | 0.080 |
Why?
| | Data Interpretation, Statistical | 1 | 2008 | 304 | 0.080 |
Why?
| | Kv1.1 Potassium Channel | 1 | 2005 | 7 | 0.070 |
Why?
| | Nicotinic Agonists | 1 | 2006 | 68 | 0.070 |
Why?
| | Radioligand Assay | 2 | 1998 | 37 | 0.070 |
Why?
| | Serotonin 5-HT2 Receptor Antagonists | 1 | 2005 | 7 | 0.070 |
Why?
| | Mesentery | 1 | 1985 | 55 | 0.070 |
Why?
| | Mountaineering | 1 | 2005 | 2 | 0.070 |
Why?
| | E1A-Associated p300 Protein | 1 | 2004 | 10 | 0.070 |
Why?
| | Benzylamines | 1 | 2004 | 16 | 0.070 |
Why?
| | Mice, Inbred Strains | 2 | 2011 | 331 | 0.070 |
Why?
| | Efferent Pathways | 2 | 2000 | 22 | 0.070 |
Why?
| | Asparagine | 1 | 2004 | 33 | 0.070 |
Why?
| | Muscle Contraction | 2 | 2001 | 306 | 0.070 |
Why?
| | Blotting, Northern | 1 | 2004 | 272 | 0.070 |
Why?
| | Glutathione Transferase | 1 | 2004 | 113 | 0.070 |
Why?
| | Spinal Cord | 1 | 1986 | 256 | 0.070 |
Why?
| | Protein Binding | 1 | 2009 | 1511 | 0.070 |
Why?
| | Pons | 1 | 2004 | 25 | 0.070 |
Why?
| | Promoter Regions, Genetic | 2 | 2000 | 944 | 0.070 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2004 | 68 | 0.070 |
Why?
| | Wakefulness | 1 | 2005 | 132 | 0.070 |
Why?
| | Pediatrics | 1 | 2009 | 349 | 0.070 |
Why?
| | Oligonucleotides | 1 | 2004 | 97 | 0.070 |
Why?
| | Vasomotor System | 3 | 1988 | 12 | 0.070 |
Why?
| | Plasmids | 1 | 2004 | 297 | 0.070 |
Why?
| | Thoracotomy | 1 | 2004 | 59 | 0.070 |
Why?
| | MAP Kinase Signaling System | 1 | 2004 | 194 | 0.070 |
Why?
| | Electron Transport Complex III | 1 | 2003 | 16 | 0.070 |
Why?
| | Receptors, Dopamine | 1 | 2003 | 44 | 0.070 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2004 | 249 | 0.070 |
Why?
| | Receptors, Muscarinic | 1 | 2003 | 54 | 0.070 |
Why?
| | Adrenergic alpha-Antagonists | 2 | 1994 | 47 | 0.070 |
Why?
| | Models, Neurological | 2 | 1999 | 431 | 0.060 |
Why?
| | Tissue Distribution | 2 | 2014 | 305 | 0.060 |
Why?
| | omega-Conotoxin GVIA | 2 | 2005 | 11 | 0.060 |
Why?
| | Respiration, Artificial | 3 | 2004 | 330 | 0.060 |
Why?
| | United States | 3 | 2010 | 6396 | 0.060 |
Why?
| | Serine | 1 | 2003 | 104 | 0.060 |
Why?
| | Brain Ischemia | 1 | 1986 | 338 | 0.060 |
Why?
| | Protein Phosphatase 1 | 1 | 2022 | 39 | 0.060 |
Why?
| | Risk Factors | 1 | 2013 | 5454 | 0.060 |
Why?
| | Aminoquinolines | 2 | 1999 | 17 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2004 | 591 | 0.060 |
Why?
| | Cerebral Cortex | 1 | 2006 | 592 | 0.060 |
Why?
| | Blood Glucose | 2 | 2019 | 904 | 0.060 |
Why?
| | Muscle Fatigue | 1 | 2001 | 8 | 0.060 |
Why?
| | Respiratory Function Tests | 1 | 2002 | 148 | 0.060 |
Why?
| | Intracellular Membranes | 1 | 2001 | 119 | 0.060 |
Why?
| | Myosin Heavy Chains | 1 | 2001 | 89 | 0.050 |
Why?
| | HEPES | 1 | 2000 | 1 | 0.050 |
Why?
| | Calcium Channel Agonists | 1 | 2000 | 16 | 0.050 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2001 | 51 | 0.050 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2000 | 154 | 0.050 |
Why?
| | Barium | 1 | 2000 | 35 | 0.050 |
Why?
| | Extracellular Space | 1 | 2000 | 104 | 0.050 |
Why?
| | Okadaic Acid | 1 | 2000 | 9 | 0.050 |
Why?
| | Buffers | 1 | 2000 | 31 | 0.050 |
Why?
| | Genome | 1 | 2003 | 364 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2019 | 1622 | 0.050 |
Why?
| | Chelating Agents | 1 | 2000 | 76 | 0.050 |
Why?
| | Acetylcholinesterase | 2 | 2003 | 48 | 0.050 |
Why?
| | src-Family Kinases | 1 | 2000 | 76 | 0.050 |
Why?
| | Heart Failure | 2 | 2011 | 1114 | 0.050 |
Why?
| | Dithionite | 1 | 1999 | 2 | 0.050 |
Why?
| | Ethylmaleimide | 1 | 1999 | 13 | 0.050 |
Why?
| | Cyanides | 1 | 1999 | 18 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 122 | 0.050 |
Why?
| | Nitroprusside | 1 | 1999 | 40 | 0.050 |
Why?
| | Genotype | 1 | 2005 | 1858 | 0.050 |
Why?
| | Nitrites | 1 | 1999 | 28 | 0.050 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 1 | 1999 | 6 | 0.050 |
Why?
| | Point Mutation | 1 | 2000 | 266 | 0.050 |
Why?
| | Heme Oxygenase-1 | 1 | 1998 | 18 | 0.050 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2000 | 145 | 0.050 |
Why?
| | Antisense Elements (Genetics) | 1 | 1998 | 9 | 0.050 |
Why?
| | Repressor Proteins | 1 | 2002 | 409 | 0.050 |
Why?
| | Imidazoline Receptors | 1 | 1998 | 2 | 0.050 |
Why?
| | Affinity Labels | 1 | 1998 | 11 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2000 | 235 | 0.050 |
Why?
| | Autoradiography | 1 | 1998 | 77 | 0.050 |
Why?
| | Aspartic Acid | 2 | 1989 | 69 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2019 | 414 | 0.050 |
Why?
| | Membranes | 1 | 1998 | 39 | 0.050 |
Why?
| | Clonidine | 1 | 1998 | 41 | 0.050 |
Why?
| | DNA | 1 | 2004 | 1307 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2020 | 568 | 0.050 |
Why?
| | Microelectrodes | 1 | 1998 | 79 | 0.050 |
Why?
| | Body Temperature | 1 | 1998 | 122 | 0.050 |
Why?
| | Drug Interactions | 2 | 2011 | 273 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 1998 | 178 | 0.050 |
Why?
| | omega-Agatoxin IVA | 1 | 1997 | 4 | 0.040 |
Why?
| | Spider Venoms | 1 | 1997 | 12 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2000 | 309 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 1999 | 182 | 0.040 |
Why?
| | Iodine Radioisotopes | 1 | 1998 | 148 | 0.040 |
Why?
| | Nitroarginine | 2 | 1995 | 16 | 0.040 |
Why?
| | NADPH Dehydrogenase | 2 | 1995 | 12 | 0.040 |
Why?
| | Cell Respiration | 1 | 2017 | 19 | 0.040 |
Why?
| | Endoplasmic Reticulum | 1 | 2019 | 255 | 0.040 |
Why?
| | Glucose | 1 | 2020 | 626 | 0.040 |
Why?
| | Adult | 3 | 2019 | 26136 | 0.040 |
Why?
| | Arginine | 2 | 1995 | 148 | 0.040 |
Why?
| | Databases, Nucleic Acid | 1 | 2016 | 44 | 0.040 |
Why?
| | Muscarinic Agonists | 1 | 1996 | 23 | 0.040 |
Why?
| | Glycolysis | 1 | 2017 | 131 | 0.040 |
Why?
| | Atmospheric Pressure | 1 | 1996 | 4 | 0.040 |
Why?
| | Chloride Channels | 1 | 1996 | 47 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 1996 | 33 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2019 | 446 | 0.040 |
Why?
| | Cholera Toxin | 1 | 1995 | 26 | 0.040 |
Why?
| | Virulence Factors, Bordetella | 1 | 1995 | 34 | 0.040 |
Why?
| | Pertussis Toxin | 1 | 1995 | 38 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2002 | 1784 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 1995 | 43 | 0.040 |
Why?
| | Swine | 1 | 2017 | 574 | 0.040 |
Why?
| | Microsomes | 1 | 1995 | 37 | 0.040 |
Why?
| | Proteolysis | 1 | 2015 | 99 | 0.040 |
Why?
| | Atropine | 2 | 2003 | 64 | 0.040 |
Why?
| | Cyclic AMP | 1 | 1996 | 280 | 0.040 |
Why?
| | Cattle | 1 | 1995 | 377 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2019 | 1912 | 0.040 |
Why?
| | Hot Temperature | 1 | 1995 | 200 | 0.040 |
Why?
| | Dopamine Antagonists | 2 | 2005 | 45 | 0.040 |
Why?
| | Receptors, Cytokine | 1 | 2014 | 23 | 0.040 |
Why?
| | Muscle, Smooth, Vascular | 1 | 1996 | 248 | 0.030 |
Why?
| | Dendrites | 1 | 1995 | 104 | 0.030 |
Why?
| | Receptors, Tachykinin | 1 | 1994 | 9 | 0.030 |
Why?
| | Sodium Bicarbonate | 1 | 1994 | 8 | 0.030 |
Why?
| | Immediate-Early Proteins | 1 | 1996 | 170 | 0.030 |
Why?
| | Response Elements | 1 | 2014 | 66 | 0.030 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1993 | 9 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 875 | 0.030 |
Why?
| | Adrenal Glands | 1 | 1994 | 83 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 902 | 0.030 |
Why?
| | Vasodilation | 1 | 2014 | 99 | 0.030 |
Why?
| | Stereoisomerism | 1 | 1993 | 101 | 0.030 |
Why?
| | Peptides | 1 | 1997 | 645 | 0.030 |
Why?
| | NF-kappa B | 1 | 2007 | 429 | 0.030 |
Why?
| | 5-Methylcytosine | 1 | 2014 | 95 | 0.030 |
Why?
| | Neuropeptides | 1 | 1994 | 116 | 0.030 |
Why?
| | Sympathectomy | 1 | 1994 | 46 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 1998 | 567 | 0.030 |
Why?
| | Adrenergic alpha-2 Receptor Antagonists | 1 | 1993 | 4 | 0.030 |
Why?
| | Cytosine | 1 | 2014 | 123 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2014 | 318 | 0.030 |
Why?
| | Infusions, Intra-Arterial | 1 | 1993 | 34 | 0.030 |
Why?
| | Glucagon | 1 | 2013 | 117 | 0.030 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2005 | 107 | 0.030 |
Why?
| | Computational Biology | 1 | 2016 | 534 | 0.030 |
Why?
| | Myocardium | 1 | 1996 | 555 | 0.030 |
Why?
| | Proinsulin | 1 | 2013 | 125 | 0.030 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2012 | 6 | 0.030 |
Why?
| | Receptors, Angiotensin | 1 | 2012 | 17 | 0.030 |
Why?
| | Mechanoreceptors | 2 | 1988 | 37 | 0.030 |
Why?
| | Type C Phospholipases | 1 | 2012 | 35 | 0.030 |
Why?
| | Transcriptome | 1 | 2016 | 528 | 0.030 |
Why?
| | Decerebrate State | 2 | 1989 | 4 | 0.030 |
Why?
| | Anesthesia | 1 | 1994 | 174 | 0.030 |
Why?
| | Baltimore | 1 | 2011 | 39 | 0.030 |
Why?
| | Urinary Bladder | 1 | 1973 | 177 | 0.030 |
Why?
| | Picrotoxin | 1 | 2011 | 7 | 0.030 |
Why?
| | 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2011 | 14 | 0.030 |
Why?
| | Bradycardia | 1 | 2011 | 41 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 1996 | 549 | 0.030 |
Why?
| | Ferrous Compounds | 1 | 2011 | 23 | 0.030 |
Why?
| | GABA Antagonists | 1 | 2011 | 30 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2011 | 51 | 0.030 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2012 | 82 | 0.030 |
Why?
| | Dopamine beta-Hydroxylase | 1 | 2011 | 7 | 0.030 |
Why?
| | Superior Cervical Ganglion | 1 | 2011 | 5 | 0.030 |
Why?
| | Cathepsin L | 1 | 2011 | 8 | 0.030 |
Why?
| | Carboxypeptidase H | 1 | 2011 | 12 | 0.030 |
Why?
| | Phenylephrine | 1 | 1991 | 40 | 0.030 |
Why?
| | Proprotein Convertase 1 | 1 | 2011 | 11 | 0.030 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2011 | 92 | 0.030 |
Why?
| | Receptors, Neurokinin-2 | 1 | 1990 | 3 | 0.030 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2011 | 23 | 0.030 |
Why?
| | Rats, Inbred Strains | 2 | 1988 | 341 | 0.030 |
Why?
| | Biophysics | 1 | 2011 | 155 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2016 | 1935 | 0.030 |
Why?
| | Ganglia, Autonomic | 2 | 2005 | 5 | 0.030 |
Why?
| | Sudden Infant Death | 1 | 1991 | 27 | 0.030 |
Why?
| | Electromyography | 2 | 1988 | 182 | 0.030 |
Why?
| | Protein Precursors | 1 | 1991 | 148 | 0.030 |
Why?
| | Pressure | 2 | 1985 | 162 | 0.030 |
Why?
| | Biguanides | 2 | 1986 | 8 | 0.030 |
Why?
| | Chemotaxis | 1 | 1990 | 75 | 0.030 |
Why?
| | Succinic Acid | 1 | 1989 | 5 | 0.030 |
Why?
| | Succinates | 1 | 1989 | 22 | 0.030 |
Why?
| | Adenosine Diphosphate | 1 | 1989 | 54 | 0.030 |
Why?
| | Heart Ventricles | 2 | 2011 | 795 | 0.020 |
Why?
| | Piperazines | 1 | 2011 | 271 | 0.020 |
Why?
| | Silver Nitrate | 1 | 1989 | 3 | 0.020 |
Why?
| | 2,4-Dinitrophenol | 1 | 1989 | 3 | 0.020 |
Why?
| | Apoptosis | 1 | 2007 | 1782 | 0.020 |
Why?
| | Spinal Nerves | 1 | 1988 | 2 | 0.020 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2009 | 16 | 0.020 |
Why?
| | Cranial Nerves | 1 | 1988 | 6 | 0.020 |
Why?
| | Amidine-Lyases | 1 | 2008 | 2 | 0.020 |
Why?
| | Somatostatin | 1 | 1988 | 60 | 0.020 |
Why?
| | Solubility | 1 | 1989 | 213 | 0.020 |
Why?
| | Naloxone | 1 | 1988 | 52 | 0.020 |
Why?
| | gamma-Aminobutyric Acid | 2 | 1986 | 103 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2008 | 103 | 0.020 |
Why?
| | Muscle Spindles | 1 | 1988 | 5 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 3729 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2009 | 107 | 0.020 |
Why?
| | Injections, Intra-Arterial | 1 | 1987 | 40 | 0.020 |
Why?
| | Kainic Acid | 1 | 1987 | 30 | 0.020 |
Why?
| | Oxadiazoles | 1 | 1987 | 40 | 0.020 |
Why?
| | Lobeline | 1 | 1986 | 4 | 0.020 |
Why?
| | Hexamethonium | 1 | 1986 | 3 | 0.020 |
Why?
| | Hexamethonium Compounds | 1 | 1986 | 6 | 0.020 |
Why?
| | Anesthesia, Local | 1 | 1986 | 30 | 0.020 |
Why?
| | Administration, Topical | 1 | 1986 | 98 | 0.020 |
Why?
| | Lidocaine | 1 | 1986 | 73 | 0.020 |
Why?
| | Butaclamol | 1 | 2005 | 1 | 0.020 |
Why?
| | Sulpiride | 1 | 2005 | 4 | 0.020 |
Why?
| | Dantrolene | 1 | 2005 | 5 | 0.020 |
Why?
| | Nimodipine | 1 | 2005 | 12 | 0.020 |
Why?
| | Nerve Growth Factor | 1 | 2005 | 26 | 0.020 |
Why?
| | Boron Compounds | 1 | 2005 | 21 | 0.020 |
Why?
| | Thapsigargin | 1 | 2005 | 55 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 1987 | 372 | 0.020 |
Why?
| | Elapid Venoms | 1 | 2005 | 8 | 0.020 |
Why?
| | Neurofilament Proteins | 1 | 2005 | 18 | 0.020 |
Why?
| | Abdominal Muscles | 1 | 1985 | 25 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2005 | 213 | 0.020 |
Why?
| | Physical Stimulation | 1 | 1985 | 71 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2005 | 65 | 0.020 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2005 | 201 | 0.020 |
Why?
| | Caffeine | 1 | 2005 | 82 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 411 | 0.020 |
Why?
| | Nitric Oxide Donors | 1 | 2003 | 14 | 0.020 |
Why?
| | Domperidone | 1 | 2003 | 8 | 0.020 |
Why?
| | Muscarinic Antagonists | 1 | 2003 | 50 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2014 | 6604 | 0.020 |
Why?
| | Intestine, Small | 1 | 1985 | 344 | 0.020 |
Why?
| | Neural Tube Defects | 1 | 2002 | 33 | 0.020 |
Why?
| | Urinary Bladder Diseases | 1 | 1982 | 39 | 0.010 |
Why?
| | Renin | 1 | 1982 | 76 | 0.010 |
Why?
| | Calcium Channels, N-Type | 1 | 2001 | 18 | 0.010 |
Why?
| | Echocardiography, Doppler | 1 | 2002 | 197 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2001 | 332 | 0.010 |
Why?
| | Cerebrovascular Circulation | 1 | 2001 | 220 | 0.010 |
Why?
| | Heart Defects, Congenital | 1 | 2002 | 352 | 0.010 |
Why?
| | 2-Amino-5-phosphonovalerate | 2 | 1989 | 14 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2005 | 1481 | 0.010 |
Why?
| | N-Methylaspartate | 2 | 1989 | 64 | 0.010 |
Why?
| | Pregnancy | 1 | 2005 | 2849 | 0.010 |
Why?
| | Aged | 2 | 2014 | 18610 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2002 | 655 | 0.010 |
Why?
| | Child | 1 | 2009 | 6847 | 0.010 |
Why?
| | Guanylate Cyclase | 1 | 1996 | 19 | 0.010 |
Why?
| | Methylene Blue | 1 | 1996 | 21 | 0.010 |
Why?
| | Isoproterenol | 1 | 1996 | 68 | 0.010 |
Why?
| | Guinea Pigs | 1 | 1996 | 179 | 0.010 |
Why?
| | Muscimol | 2 | 1986 | 17 | 0.010 |
Why?
| | Receptors, Adrenergic, beta | 1 | 1996 | 74 | 0.010 |
Why?
| | Middle Aged | 2 | 2014 | 25701 | 0.010 |
Why?
| | Temperature | 2 | 1987 | 424 | 0.010 |
Why?
| | Pentolinium Tartrate | 1 | 1973 | 1 | 0.010 |
Why?
| | Reserpine | 1 | 1973 | 6 | 0.010 |
Why?
| | Dilatation | 1 | 1973 | 46 | 0.010 |
Why?
| | Dogs | 1 | 1973 | 805 | 0.010 |
Why?
| | Vertebral Artery | 1 | 1992 | 24 | 0.010 |
Why?
| | Sodium Chloride | 1 | 1992 | 93 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 1992 | 269 | 0.010 |
Why?
| | Dipyridamole | 1 | 1989 | 13 | 0.010 |
Why?
| | Aminophylline | 1 | 1989 | 15 | 0.010 |
Why?
| | Glossopharyngeal Nerve | 1 | 1988 | 1 | 0.010 |
Why?
| | Recurrent Laryngeal Nerve | 1 | 1988 | 11 | 0.010 |
Why?
| | Breath Tests | 1 | 1988 | 54 | 0.010 |
Why?
| | Nerve Block | 1 | 1988 | 58 | 0.010 |
Why?
| | Cervical Plexus | 1 | 1987 | 5 | 0.010 |
Why?
| | Quisqualic Acid | 1 | 1987 | 7 | 0.010 |
Why?
| | Glutamates | 1 | 1987 | 94 | 0.010 |
Why?
| | Valine | 1 | 1987 | 77 | 0.010 |
Why?
| | Chloralose | 1 | 1986 | 7 | 0.010 |
Why?
| | Anesthesia, General | 1 | 1986 | 135 | 0.000 |
Why?
| | Aorta | 1 | 1985 | 300 | 0.000 |
Why?
|
|
Prabhakar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|